Loading
Latest filing published 02 Jul 2024 for Tempest Therapeutics, Inc., €15k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
One trade, one date: on 2 July 2024, Justin Trojanowski disclosed an open-market purchase of €15k in Tempest Therapeutics, Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration